Skip to main content
. 2022 Mar 3;38(2):362–371. doi: 10.1093/ndt/gfac056

FIGURE 5:

FIGURE 5:

Percentage of patients with a CP activity <10% over time for the standard dosing regimen (grey line) and an individualized, TDM-based dosing regimen (black line).